Kim Christopher (CIK 2040022) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-05-20). Recent activity: Buy APUS (250,000 shares), Buy APUS (19,770 shares), Buy APUS (7,730 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-20 | Apimeds Pharmaceuticals US, Inc. (APUS) | Chairman and CMO | Buy | 250,000 | $0 |
| 2025-05-15 | Apimeds Pharmaceuticals US, Inc. (APUS) | Chairman and CMO | Buy | 19,770 | $0 |
| 2025-05-15 | Apimeds Pharmaceuticals US, Inc. (APUS) | Chairman and CMO | Buy | 7,730 | $0 |
Source: SEC Form 4 filings · as of 2025-05-20